Last 12 months
Inside the activity.
1 purchase rows · 109 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 20 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 24 |
| Mar 2026 | 0 | 19 |
| Apr 2026 | 0 | 19 |
| May 2026 | 1 | 7 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 23, 2019 Filed Jan 25, 2019 02:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 1,910 | $31.58 | $60,317.80 |
DisclosureSEC source: 0001144204-19-002703 · tv511485_4.xml · nonDerivative · entry 4 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.10 to $32.07, inclusive. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 02:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-002703 · tv511485_4.xml · nonDerivative · entry 3 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 22, 2019 Filed Jan 25, 2019 02:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002703 · tv511485_4.xml · derivative · entry 8 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,780 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 22, 2019 Filed Jan 25, 2019 02:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $31.40 | $78,500.00 |
DisclosureSEC source: 0001144204-19-002703 · tv511485_4.xml · nonDerivative · entry 2 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.15 to $31.82, inclusive. Read SEC document |
| January 22, 2019 Filed Jan 25, 2019 02:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-002703 · tv511485_4.xml · nonDerivative · entry 1 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 18, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · derivative · entry 10 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,280 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 18, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $32.04 | $80,100.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · nonDerivative · entry 6 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.88 to $32.19, inclusive. Read SEC document |
| January 18, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · nonDerivative · entry 5 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 17, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 110 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · derivative · entry 9 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,780 Underlying: Class A Common Stock · 110 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 17, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,390 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · derivative · entry 8 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,390 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 17, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $32.24 | $80,600.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · nonDerivative · entry 4 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.09 to $32.42, inclusive. Read SEC document |
| January 17, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · nonDerivative · entry 3 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · derivative · entry 7 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,390 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $32.40 | $81,000.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · nonDerivative · entry 2 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.13 to $32.51, inclusive. Read SEC document |
| January 16, 2019 Filed Jan 19, 2019 02:00 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-002146 · tv511196_4.xml · nonDerivative · entry 1 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
Exercise / conversionOption to purchase Class A Common Stock · Derivative | 19,890 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · derivative · entry 4 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 19,890 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
Exercise / conversionOption to purchase Class A Common Stock · Derivative | 1,670 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · derivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,670 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
SaleClass A Common Stock | 21,560 | $31.81 | $685,823.60 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.49 to $32.38, inclusive. Read SEC document |
| January 15, 2019 Filed Jan 18, 2019 02:13 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
Exercise / conversionClass A Common Stock | 21,560 | $11.83 | $255,054.80 |
DisclosureSEC source: 0001144204-19-002032 · tv511175_4.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 02:14 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-001393 · tv510834_4.xml · derivative · entry 6 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,890 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 02:14 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $32.54 | $81,350.00 |
DisclosureSEC source: 0001144204-19-001393 · tv510834_4.xml · nonDerivative · entry 4 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 02:14 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-001393 · tv510834_4.xml · nonDerivative · entry 3 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 08, 2019 Filed Jan 11, 2019 02:14 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-001393 · tv510834_4.xml · derivative · entry 5 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,390 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 08, 2019 Filed Jan 11, 2019 02:14 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $32.31 | $80,775.00 |
DisclosureSEC source: 0001144204-19-001393 · tv510834_4.xml · nonDerivative · entry 2 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 08, 2019 Filed Jan 11, 2019 02:14 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-001393 · tv510834_4.xml · nonDerivative · entry 1 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 07, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · derivative · entry 9 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,890 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 07, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $32.21 | $80,525.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · nonDerivative · entry 6 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 07, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · nonDerivative · entry 5 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · derivative · entry 8 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,390 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $31.30 | $78,250.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · nonDerivative · entry 4 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · nonDerivative · entry 3 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 03, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · derivative · entry 7 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,890 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 03, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $31.72 | $79,300.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · nonDerivative · entry 2 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| January 03, 2019 Filed Jan 8, 2019 01:08 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-19-000965 · tv510380_4.xml · nonDerivative · entry 1 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
Exercise / conversionOption to purchase Class A Common Stock · Derivative | 10,000 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · derivative · entry 4 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,670 Underlying: Class A Common Stock · 10,000 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
SaleClass A Common Stock | 200 | $43.40 | $8,680.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · nonDerivative · entry 3 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
SaleClass A Common Stock | 9,800 | $42.83 | $419,734.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · nonDerivative · entry 2 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.25 to $43.23, inclusive. Read SEC document |
| November 01, 2018 Filed Nov 6, 2018 02:07 UTC |
Warras Dean JPres Animal Health & Nutr N.A.
|
Exercise / conversionClass A Common Stock | 10,000 | $11.83 | $118,300.00 |
DisclosureSEC source: 0001144204-18-057399 · tv506174_form4.xml · nonDerivative · entry 1 Warras Dean J · CIK 0001601562 · Pres Animal Health & Nutr N.A. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:04 UTC |
BFI Co., LLC10% owner
|
ConversionClass B Common Stock · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-049581 · tv502927_4.xml · derivative · entry 3 BFI Co., LLC · CIK 0001601607 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,166,034 Underlying: Class A Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F1 · derivative.exercise_date: Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date. F1 · derivative.expiration_date: Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:04 UTC |
BFI Co., LLC10% owner
|
SaleClass A Common Stock | 520 | $45.04 | $23,420.80 |
DisclosureSEC source: 0001144204-18-049581 · tv502927_4.xml · nonDerivative · entry 2 BFI Co., LLC · CIK 0001601607 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,480 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.10, inclusive. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:04 UTC |
BFI Co., LLC10% owner
|
ConversionClass A Common Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-049581 · tv502927_4.xml · nonDerivative · entry 1 BFI Co., LLC · CIK 0001601607 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionOption to purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $11.83 | $0.00 |
DisclosureSEC source: 0001144204-18-049580 · tv502926_4.xml · derivative · entry 3 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,390 Underlying: Class A Common Stock · 2,500 shares Expires 2019-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
SaleClass A Common Stock | 2,500 | $44.30 | $110,750.00 |
DisclosureSEC source: 0001144204-18-049580 · tv502926_4.xml · nonDerivative · entry 2 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:04 UTC |
Bendheim Daniel MDirector · Exec. VP, Corporate Strategy
|
Exercise / conversionClass A Common Stock | 2,500 | $11.83 | $29,575.00 |
DisclosureSEC source: 0001144204-18-049580 · tv502926_4.xml · nonDerivative · entry 1 Bendheim Daniel M · CIK 0001601576 · Director · Exec. VP, Corporate Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2018, as amended on September 12, 2018. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:03 UTC |
BENDHEIM JACKDirector · President and CEO · 10% owner
|
ConversionClass B Common Stock · Derivative | 30,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-049579 · tv502904_4.xml · derivative · entry 3 BENDHEIM JACK · CIK 0001241560 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 20,166,034 Underlying: Class A Common Stock · 30,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F1 · derivative.exercise_date: Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date. F1 · derivative.expiration_date: Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date. F3 · ownership.nature: The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:03 UTC |
BENDHEIM JACKDirector · President and CEO · 10% owner
|
SaleClass A Common Stock | 520 | $45.04 | $23,420.80 |
DisclosureSEC source: 0001144204-18-049579 · tv502904_4.xml · nonDerivative · entry 2 BENDHEIM JACK · CIK 0001241560 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 59,480 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.10, inclusive. F3 · ownership.nature: The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 12, 2018 Filed Sep 15, 2018 01:03 UTC |
BENDHEIM JACKDirector · President and CEO · 10% owner
|
ConversionClass A Common Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-049579 · tv502904_4.xml · nonDerivative · entry 1 BENDHEIM JACK · CIK 0001241560 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F3 · ownership.nature: The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI Co., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 01:26 UTC |
BENDHEIM JACKDirector · President and CEO · 10% owner
|
SaleClass A Common Stock | 600 | $47.47 | $28,482.00 |
DisclosureSEC source: 0001144204-18-048381 · tv502250_4.xml · nonDerivative · entry 4 BENDHEIM JACK · CIK 0001241560 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 30,000 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.45 to $47.50, inclusive. F3 · ownership.nature: The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFICo., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 01:26 UTC |
BENDHEIM JACKDirector · President and CEO · 10% owner
|
SaleClass A Common Stock | 9,400 | $46.94 | $441,236.00 |
DisclosureSEC source: 0001144204-18-048381 · tv502250_4.xml · nonDerivative · entry 3 BENDHEIM JACK · CIK 0001241560 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 30,600 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.40, nclusive. F3 · ownership.nature: The securities are held by BFI Co., LLC. Mr. Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFICo., LLC and may be deemed to have shared voting and investment power over the securities held by BFI Co., LLC. Mr. Bendheim disclaims beneficialownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 06, 2018 Filed Sep 7, 2018 01:24 UTC |
BFI Co., LLC10% owner
|
SaleClass A Common Stock | 600 | $47.47 | $28,482.00 |
DisclosureSEC source: 0001144204-18-048380 · tv502248_4.xml · nonDerivative · entry 4 BFI Co., LLC · CIK 0001601607 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.45 to $47.50, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.